Vergleich

CDR2 Polyclonal Antibody

ArtNr E-AB-11068-200
Hersteller Elabscience
Menge 200 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Kategorie
Typ Antibody Polyclonal
Applikationen IHC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host Rabbit
Isotype IgG
Konjugat/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias AA617262, CDR 2, CDR 62, CDR2, CDR2, CDR62, Cerebellar degeneration related protein 2 62kDa, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, MGC116181, MGC144810, MGC144811, Paraneoplastic cerebellar degeneration associated antigen, Paraneoplastic cerebellar degeneration-associated antigen, PCD 17, PCD17, RGD1310578, Yo, Yo paraneoplastic antigen
Similar products CDR2, Paraneoplastic cerebellar degeneration-associated antigen, PCD17, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, CDR62, Yo, Yo paraneoplastic antigen, CDR 2, CDR 62, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Paraneoplastic cerebellar degeneration associated antigen, PCD 17, AA617262, Cerebellar degeneration related protein 2 62kDa, MGC116181, MGC144810, MGC144811, RGD1310578
Versandbedingung Gekühlt
Gefahren-Info Comply with cargo safety certificate
Lieferbar
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
CDR2
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Manufacturer - Research Areas
Cancer, Immunology
Background
CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.
Concentration
0.4 mg/mL
Buffer
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method
Affinity purification
Recommended Dilution
IHC 1:50-1:200
Santa Cruz #
sc-109228
Abbreviation
CDR2
Clonality
Polyclonal
Immunogen
Recombinant protein of human CDR2
Category ID III
Polyclonal Antibodies

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 200 uL
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?